Radioiodinated antibody targeting of the HER-2/neu oncoprotein: effects of labeling method on cellular processing and tissue distribution-Reference-Cited by-同舟云学术

Radioiodinated antibody targeting of the HER-2/neu oncoprotein: effects of labeling method on cellular processing and tissue distribution

Published:1999-10 Issue:7 Volume:26 Page:781-790
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Zalutsky M.R,Xu F.J,Yu Y,Foulon C.F,Zhao X.-G,Slade S.K,Affleck D.J,Bast R.C

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference36 articles.

1. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single chain Fv;Adams;Cancer Res,1993

2. Improving the tumor retention of radioiodinated antibody;Ali;Cancer Res,1990

3. Recombinant humanized anti-HER2 antibody (Herceptin™) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts;Baselga;Cancer Res,1998

4. Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin;Batra;Proc. Natl. Acad. Sci. USA,1992

5. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer;Berchuck;Cancer Res,1990

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radioiodine based biomedical carriers for cancer theranostics;Coordination Chemistry Reviews;2023-12

2. Understanding the in vivo fate of radioimmunoconjugates for nuclear imaging;Journal of Labelled Compounds and Radiopharmaceuticals;2018-05-14

3. General overview of radioimmunotherapy of solid tumors;Immunotherapy;2013-05

4. Preclinical development of molecular-targeted agents for cancer;Nature Reviews Clinical Oncology;2010-12-07

5. The Radiochemistry of Monoclonal Antibodies and Peptides;Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer;2010-07-15